Cargando…
Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a)
Lipoprotein(a) [Lp(a)] is an unique lipoprotein consisting of the glycoprotein apolipoprotein(a) [apo(a)] in low-density lipoprotein. Although Lp(a) is a well-known independent risk factor for cardiovascular disease; however, there is no drugs to decrease plasma Lp(a) level. Thus, to inhibit the bio...
Autores principales: | Kyutoku, Mariko, Nakagami, Hironori, Koriyama, Hiroshi, Nakagami, Futoshi, Shimamura, Munehisa, Kurinami, Hitomi, Tomioka, Hideki, Miyake, Takashi, Katsuya, Tomohiro, Morishita, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615337/ https://www.ncbi.nlm.nih.gov/pubmed/23549288 http://dx.doi.org/10.1038/srep01600 |
Ejemplares similares
-
Development of novel DNA vaccine for VEGF in murine cancer model
por: Kyutoku, Mariko, et al.
Publicado: (2013) -
Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
por: Nakagami, Futoshi, et al.
Publicado: (2013) -
A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
por: Kurinami, Hitomi, et al.
Publicado: (2016) -
Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
por: Shimamura, Munehisa, et al.
Publicado: (2013) -
AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019)